Lisa A. Mango - Oct 17, 2022 Form 4 Insider Report for 1Life Healthcare Inc (ONEM)

Signature
/s/ Ivy Tseng, Attorney-in-Fact for Lisa A Mango
Stock symbol
ONEM
Transactions as of
Oct 17, 2022
Transactions value $
-$26,078
Form type
4
Date filed
10/19/2022, 08:59 PM
Previous filing
Aug 10, 2022
Next filing
Oct 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONEM Common Stock Options Exercise $30.1K +2.47K +2.8% $12.16 90.9K Oct 17, 2022 Direct
transaction ONEM Common Stock Sale -$42.2K -2.47K -2.72% $17.06 88.4K Oct 17, 2022 Direct F1, F2
transaction ONEM Common Stock Options Exercise $28.7K +2.5K +2.83% $11.47 90.9K Oct 19, 2022 Direct
transaction ONEM Common Stock Sale -$42.6K -2.5K -2.75% $17.06 88.4K Oct 19, 2022 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ONEM Stock Options (Right to buy) Options Exercise $0 -2.47K -2.5% $0.00 96.4K Oct 17, 2022 Common Stock 2.47K $12.16 Direct F4, F5
transaction ONEM Stock Option (Right to Buy) Options Exercise $0 -2.5K -4.17% $0.00 57.5K Oct 19, 2022 Common Stock 2.5K $11.47 Direct F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and were conducted by the reporting person for tax and estate planning purposes. The reporting person has adopted Rule 10b5-1 plans in the past and has adopted this Rule 10b5-1 plan in the ordinary course. The trading plans and their parameters do not reflect the reporting person's views on the closing of the pending, previously announced, merger or the prospects of the Company's business after the closing.
F2 This transaction was executed in multiple trades at prices ranging from $17.045 to $17.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $17.05 to $17.065. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years commencing on the vesting commencement date, subject to reporting person's continuous service as of each such date.
F5 On October 6, 2022, the reporting person filed a Form 4 in which the number of derivative securities beneficially owned following the reported transaction should have been 98,892 options instead of the reported 91,293. This number has been adjusted for the current filing to reflect the number of options beneficially owned.
F6 The shares subject to the option vest as follows: 20% of the shares subject to the option vest on the first anniversary of the vesting commencement date; and 1/60th of the shares subject to the option vest monthly thereafter over the following four years, subject to reporting person's continuous service as of each such date.
F7 On October 6, 2022, the reporting person filed a Form 4 in which the number of derivative securities beneficially owned following the reported transaction should have been 60,000 options instead of the reported 42,564. This number has been adjusted for the current filing to reflect the number of options beneficially owned.